Home / Journals / CJU / Vol.26, No.2, 2019
Special Issues
  • Open AccessOpen Access

    BOOK REVIEW

    Hormone Therapy and Castration Resistance of Prostate Cancer

    Yoichi Arai, Osamu Ogawa
    Canadian Journal of Urology, Vol.26, No.2, pp. 9686-9686, 2019
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    EDITORIAL

    Is BCG a Hazardous Drug? Ask NIOSH, OSHA, and the USP

    Leonard G. Gomella
    Canadian Journal of Urology, Vol.26, No.2, pp. 9687-9689, 2019
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    LEGENDS IN UROLOGY

    LEGENDS IN UROLOGY

    David A. Bloom
    Canadian Journal of Urology, Vol.26, No.2, pp. 9690-9693, 2019
    Abstract This article has no abstract. More >

  • Open AccessOpen Access

    ARTICLE

    Overlapping surgeries: defining the “critical portions” of the procedure

    Joon Yau Leong, Brian Calio, Mihir Shah, Patrick Sullivan, Edouard J. Trabulsi, Leonard G. Gomella, Costas D. Lallas
    Canadian Journal of Urology, Vol.26, No.2, pp. 9694-9698, 2019
    Abstract Introduction: An important aspect of overlapping surgery is to determine the “critical portion” of an operation. Currently, there are no guidelines that standardize the critical portions of common urologic procedures. We sought to determine the relationship between the critical portions of common urologic operations as defined by the primary surgeon compared to the trainee at a single academic medical center.
    Materials and methods: In an open-ended survey of the Urology Department at Thomas Jefferson University, attending surgeons and urology residents were asked to list five of their most commonly performed surgeries and subsequently identify what they defined… More >

  • Open AccessOpen Access

    ARTICLE

    Outcomes of upper tract urothelial cancer managed non-surgically

    Jamil S. Syed1, Kevin A. Nguyen1, Alfie Suarez-Sariemento1, Cynthia Leung1, Marianne Casilla-Lennon1, Jay D. Raman2, Brian Shuch1,3
    Canadian Journal of Urology, Vol.26, No.2, pp. 9699-9707, 2019
    Abstract Introduction: Approximately 7% of patients with localized upper tract urothelial cancer (UTUC) are treated without definitive therapy. Understanding outcomes and alternative therapy would aid in counseling older patients with comorbidities.
    Materials and methods: We utilized the National Cancer Database to identify patients with localized UTUC managed non-surgically between 2004 and 2013. Patient demographics, comorbidity, tumor grade, and chemotherapy and radiation utilization were recorded. Survival analyses were performed with the Kaplan-Meier method and a Cox proportional hazard regression model.
    Results: We identified 3157 (10.9%) patients with localized UTUC who did not receive definitive surgery. Median age was 79 years,… More >

  • Open AccessOpen Access

    ARTICLE

    Return to work after robot-assisted laparoscopic prostatectomy versus radical retro-pubic prostatectomy

    Andrew Salner1, Ilene Staff2, Rene I. Jahiel1, Keith M. Bellizzi3, Alison Champagne2, Joseph Tortora2, Alison G. Wong3, Tara McLaughlin4, Joseph Wagner4
    Canadian Journal of Urology, Vol.26, No.2, pp. 9708-9714, 2019
    Abstract Introduction: We compared the return-to-work interval (RTWI) after radical retro-pubic prostatectomy (RRP) and robot-assisted laparoscopic prostatectomy (RALP) in men being treated for early-stage prostate cancer.
    Materials and methods: We mailed a 28-item questionnaire to a random sample of 2,696 patients who either had RRP from 1995 to 2004 or RALP from 2004 to 2011.
    Results: We received analyzable questionnaires from 315 patients; 178 had RALP and 137 had RRP. The median RTWI was shorter in the RALP group than in the RRP group (3 versus 4 weeks, p = .016). The percent of subjects who had not returned More >

  • Open AccessOpen Access

    ARTICLE

    Prognostic implications of renal vein involvement in T3a renal cancer

    Kellan F. Clark1, Matthew Risendal1, Sharon Hill2, Samuel Deem3
    Canadian Journal of Urology, Vol.26, No.2, pp. 9715-9719, 2019
    Abstract Introduction: The TNM staging system is used globally as the standard for interpreting the extent of cancer. Currently, T3a renal cell carcinoma is classified as tumor extending into the perinephric fat or renal vein. Prognostic outcomes may vary among renal cell carcinomas with renal vein involvement (RVI) versus those with perinephric fat involvement (PFI).
    Materials and methods: We reviewed the medical records of all patients who underwent radical or partial nephrectomy at our institution by a single group of urologists between 2000 and 2014. After identifying those patients with T3a renal cell carcinoma, we further analyzed their… More >

  • Open AccessOpen Access

    ARTICLE

    Assessment of complications following urinary diversion for benign indications

    Jacqueline Zillioux1, David Rapp1, Luriel Smith-Harrison2, Matthew Wang1, Raymond Costabile1
    Canadian Journal of Urology, Vol.26, No.2, pp. 9720-9725, 2019
    Abstract Introduction: To evaluate complications following urinary diversion for non-malignant conditions.
    Materials and methods: We performed a retrospective review of patients undergoing urinary diversion for benign indications between 2000 and 2017. Data collected including patient demographic and clinical characteristics, surgical characteristics, and complications. Complications were graded using Clavien-Dindo classification and were categorized as early versus delayed (≤ versus > 90 day postoperatively). Logistic regression assessed for predictors of developing any postoperative complication.
    Results: A total of 68 patients were identified for study analysis with median follow up of 24 (7-72) months. Sixty-eight percent and 25% of patients underwent diversion… More >

  • Open AccessOpen Access

    ARTICLE

    Factors associated with prolonged length of stay following robotic-assisted partial nephrectomy

    Ashley M. Shumate1, Grayson Roth2, Colleen T. Ball2, Kaitlynn Custer2, David D. Thiel1
    Canadian Journal of Urology, Vol.26, No.2, pp. 9726-9732, 2019
    Abstract Introduction: To prospectively analyze the association of clinical and operative variables on patient length of hospital stay (LOS) following robotic-assisted partial nephrectomy (RAPN) and develop an accurate clinical-based scoring system to predict prolonged LOS following RAPN.
    Materials and methods: We analyzed 304 consecutive RAPNs performed by a single surgeon. Prolonged LOS was defined as greater than 3 days of hospitalization postoperatively. Preoperative clinical factors and operative variables were analyzed for association with LOS. After adjusting for multiple testing, p ≤ 0.004 was considered statistically significant.
    Results: LOS was 1 day in 17 (5.6%) patients, 2 days in 136… More >

  • Open AccessOpen Access

    ARTICLE

    The safety wire with a ureteral access sheath – does it hurt more than it helps? Karen L. Stern, MD,1 Donald Fedrigon III, BS,1 Christopher

    Karen L. Stern1, Donald Fedrigon III1, Christopher J. Loftus2, Manoj Monga1
    Canadian Journal of Urology, Vol.26, No.2, pp. 9733-9735, 2019
    Abstract Introduction: Studies indicate that with a safety wire in the ureter, an increased amount of force is necessary to advance ureteral access sheaths up to the proximal ureter. Theoretically, the compression of the ureter with the wire could lead to an increase in number and severity of ureteral injuries secondary to placement of a sheath. This prospective study aims to evaluate if there is a correlation between the use of a safety wire and ureteral injury from sheath placement by evaluating the location of the wire in relation to the injury after ureteroscopy.
    Materials and Methods: Fifty-nine… More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Placenta percreta into the urinary bladder: the importance of the urologist

    Humberto Vigil1, Sender Herschorn1, Ron Kodama1, Jon Barrett2
    Canadian Journal of Urology, Vol.26, No.2, pp. 9736-9739, 2019
    Abstract The incidence of placenta accreta spectrum is on the rise. The most serious entity within this spectrum is percreta: extension beyond the uterus. The bladder is most commonly involved in these cases and is especially relevant for the urologist. Important sequelae include hemorrhage, massive transfusion, maternal mortality and urinary tract injury. Approaching this disorder as well as associated urinary tract involvement in a standardized and multi-disciplinary fashion significantly improves outcomes and reduces morbidity. Herein, we present a case of complete placenta percreta involving the bladder that was successfully managed with minimal obstetrical and genitourinary morbidity. More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Ex-vivo donor partial nephrectomy at the time of donor-directed renal transplantation

    Eric C. Wendel, Raunak D. Patel, Daniel J. Canter
    Canadian Journal of Urology, Vol.26, No.2, pp. 9740-9742, 2019
    Abstract The outcome of nephron-sparing surgical management of small renal masses is generally favorable, specifically in terms of long term renal function, overall survival, and oncologic outcomes. Given the overall prognosis and renal function preservation, transplantation of kidneys with small renal masses has increasingly been accepted as a donor option for renal transplantation. We present a case of an incidental renal mass on preoperative donor transplant evaluation and subsequent ex-vivo donor partial nephrectomy at the time of renal transplantation. More >

  • Open AccessOpen Access

    RESIDENT’S CORNER

    Long term control and preservation of renal function after multiple courses of stereotactic body radiation therapy for renal cell carcinoma

    Abhinav V. Reddy1,2, Matthew N. Mills1,3, Stanley L. Liauw4, Sujith Baliga5, Charles R. Kersh6
    Canadian Journal of Urology, Vol.26, No.2, pp. 9743-9745, 2019
    Abstract Renal cell carcinoma (RCC) is usually treated with surgery, with or without systemic therapy. For select patients, stereotactic body radiation therapy (SBRT) may be a suitable alternative. Although many reports exist on the successful use of SBRT, very few have described long term outcomes with regard to disease progression and renal function. We report a rare case of a single patient with primary, metastatic, and locally recurrent renal cell carcinoma who was successfully treated with SBRT. The patient has been disease-free for 8 years since treatment, with stable renal function even after two courses of More >

Per Page:

Share Link